Serguei Maliartchouk, Ph.D. - Publications
Affiliations: | 2001 | McGill University, Montreal, QC, Canada |
Area:
Pharmacology, Neuroscience Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2000 | Beglova N, Maliartchouk S, Ekiel I, Zaccaro MC, Saragovi HU, Gehring K. Design and solution structure of functional peptide mimetics of nerve growth factor. Journal of Medicinal Chemistry. 43: 3530-40. PMID 11000007 DOI: 10.1021/Jm990441X | 0.567 | |||
2000 | Maliartchouk S, Debeir T, Beglova N, Cuello AC, Gehring K, Saragovi HU. Genuine monovalent ligands of TrkA nerve growth factor receptors reveal a novel pharmacological mechanism of action. The Journal of Biological Chemistry. 275: 9946-56. PMID 10744669 DOI: 10.1074/Jbc.275.14.9946 | 0.613 | |||
2000 | Maliartchouk S, Feng Y, Ivanisevic L, Debeir T, Cuello AC, Burgess K, Saragovi HU. A designed peptidomimetic agonistic ligand of TrkA nerve growth factor receptors. Molecular Pharmacology. 57: 385-91. PMID 10648649 | 0.612 | |||
1998 | Saragovi HU, Zheng W, Maliartchouk S, DiGugliemo GM, Mawal YR, Kamen A, Woo SB, Cuello AC, Debeir T, Neet KE. A TrkA-selective, fast internalizing nerve growth factor-antibody complex induces trophic but not neuritogenic signals. The Journal of Biological Chemistry. 273: 34933-40. PMID 9857023 DOI: 10.1074/Jbc.273.52.34933 | 0.607 | |||
1997 | Maliartchouk S, Saragovi HU. Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 6031-7. PMID 9236214 DOI: 10.1523/Jneurosci.17-16-06031.1997 | 0.614 | |||
1996 | LeSauteur L, Maliartchouk S, Le Jeune H, Quirion R, Saragovi HU. Potent human p140-TrkA agonists derived from an anti-receptor monoclonal antibody. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 1308-16. PMID 8778282 DOI: 10.1523/Jneurosci.16-04-01308.1996 | 0.625 | |||
Show low-probability matches. |